UOC

UBS O'Connor Portfolio holdings

AUM $1.93B
1-Year Return 38.75%
This Quarter Return
+15.38%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$3.3B
AUM Growth
-$463M
Cap. Flow
-$632M
Cap. Flow %
-19.12%
Top 10 Hldgs %
73.53%
Holding
460
New
59
Increased
65
Reduced
85
Closed
138
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MLCO icon
201
Melco Resorts & Entertainment
MLCO
$3.8B
$405K 0.01%
+76,800
New +$405K
LRMR icon
202
Larimar Therapeutics
LRMR
$337M
$387K 0.01%
180,027
-8,516
-5% -$18.3K
BMRN icon
203
BioMarin Pharmaceuticals
BMRN
$11.1B
$372K 0.01%
5,258
-21,582
-80% -$1.53M
GRAB icon
204
Grab
GRAB
$21B
$318K 0.01%
+70,291
New +$318K
TRML icon
205
Tourmaline Bio
TRML
$687M
$272K 0.01%
+17,860
New +$272K
ORIC icon
206
Oric Pharmaceuticals
ORIC
$1.06B
$266K 0.01%
47,642
-127,204
-73% -$710K
LION icon
207
Lionsgate Studios Corp.
LION
$1.78B
$261K 0.01%
35,000
-95,774
-73% -$715K
CGEM icon
208
Cullinan Oncology
CGEM
$413M
$249K 0.01%
32,903
-23,192
-41% -$176K
DYN icon
209
Dyne Therapeutics
DYN
$2.02B
$224K 0.01%
21,422
+8,838
+70% +$92.4K
DRUG
210
Bright Minds Biosciences
DRUG
$299M
$215K 0.01%
+5,963
New +$215K
EH
211
EHang Holdings
EH
$1.16B
$209K 0.01%
+10,000
New +$209K
ARQT icon
212
Arcutis Biotherapeutics
ARQT
$2.06B
$206K 0.01%
13,201
-64,354
-83% -$1.01M
CATX icon
213
Perspective Therapeutics
CATX
$257M
$205K 0.01%
96,060
-27,183
-22% -$57.9K
ABBV icon
214
AbbVie
ABBV
$375B
$204K 0.01%
973
-6,515
-87% -$1.37M
SLN
215
Silence Therapeutics
SLN
$269M
$177K 0.01%
62,639
-66,351
-51% -$187K
CNTB
216
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
$97.5M
$148K ﹤0.01%
268,946
-241,755
-47% -$133K
AMC icon
217
AMC Entertainment Holdings
AMC
$1.41B
$114K ﹤0.01%
39,688
-36,306
-48% -$104K
ERAS icon
218
Erasca
ERAS
$457M
$104K ﹤0.01%
75,627
-153,973
-67% -$211K
KPTI icon
219
Karyopharm Therapeutics
KPTI
$57.2M
$88.4K ﹤0.01%
23,640
-75,275
-76% -$282K
EVLVW icon
220
Evolv Technologies Holdings, Inc. Warrant
EVLVW
$11.6M
$77K ﹤0.01%
463,341
VYNE icon
221
VYNE Therapeutics
VYNE
$7.62M
$72K ﹤0.01%
45,557
-200,243
-81% -$316K
CLBR.WS
222
DELISTED
Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
CLBR.WS
$69.3K ﹤0.01%
90,000
-10,000
-10% -$7.7K
CRVS icon
223
Corvus Pharmaceuticals
CRVS
$459M
$66.3K ﹤0.01%
20,850
-19,150
-48% -$60.9K
CCCC icon
224
C4 Therapeutics
CCCC
$194M
$63.8K ﹤0.01%
39,868
-97,492
-71% -$156K
XFOR icon
225
X4 Pharmaceuticals
XFOR
$78.6M
$59.6K ﹤0.01%
8,420
-33,725
-80% -$239K